Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Tailored medical and interventional therapy against recurrent stent thrombosis after drug-eluting stenting.

Campo G, Valgimigli M, Carrescia C, Carletti R, Ferrari R.

Clin Appl Thromb Hemost. 2010 Oct;16(5):591-3. doi: 10.1177/1076029609337312. Epub 2009 Jun 10.

PMID:
19520678
2.

Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis.

Pinto Slottow TL, Bonello L, Gavini R, Beauzile P, Sushinsky SJ, Scheinowitz M, Kaneshige K, Xue Z, Torguson R, Tantry U, Pichard AD, Satler LF, Suddath WO, Kent K, Gurbel P, Waksman R.

Am J Cardiol. 2009 Aug 15;104(4):525-30. doi: 10.1016/j.amjcard.2009.04.015. Epub 2009 Jun 24.

PMID:
19660606
3.

Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.

Wang ZJ, Zhou YJ, Liu YY, Yu M, Shi DM, Zhao YX, Guo YH, Cheng WJ, Jia de A, Cao Z, Nie B, Ge HL, Yang SW, Yan ZX.

Thromb Res. 2009 May;124(1):46-51. doi: 10.1016/j.thromres.2008.10.007. Epub 2008 Nov 28.

PMID:
19041120
4.
5.

[Late thrombosis in paclitaxel-eluting stent after discontinuation of clopidogrel medication - a case report with 2-year follow-up].

Wozakowska-Kapłon B, Młodnicki M, Gutkowski W.

Kardiol Pol. 2009 Mar;67(3):299-303; discussion 304. Polish.

6.

Recurrent episodes of very late stent thrombosis in a patient with aspirin hypersensitivity, stent fracture and malapposition.

Barison A, de Carlo M, Bellini F, Capozza PF, Lunardini A, Petronio AS.

Acute Card Care. 2011 Mar;13(1):52-4. doi: 10.3109/17482941.2011.553288. Epub 2011 Feb 16.

PMID:
21323408
7.

Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).

Tanzilli G, Greco C, Pelliccia F, Pasceri V, Barillà F, Paravati V, Pannitteri G, Gaudio C, Mangieri E.

Am J Cardiol. 2009 Nov 15;104(10):1357-61. doi: 10.1016/j.amjcard.2009.07.002. Epub 2009 Sep 26.

PMID:
19892050
8.

[Severe myocardial infarction due to late and very late stent thrombosis after coronary artery stenting with drug-eluting stents].

Krausgrill B, Erdmann E, Flesch M.

Dtsch Med Wochenschr. 2008 Oct;133(40):2014-7. doi: 10.1055/s-0028-1085610. Epub 2008 Sep 25. German.

PMID:
18819044
9.

Clopidogrel as adjunctive antiplatelet therapy during coronary stenting.

Mishkel GJ, Aguirre FV, Ligon RW, Rocha-Singh KJ, Lucore CL.

J Am Coll Cardiol. 1999 Dec;34(7):1884-90.

10.

Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.

Roy P, Bonello L, Torguson R, Okabe T, Pinto Slottow TL, Steinberg DH, Kaneshige K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R.

Am J Cardiol. 2009 Mar 15;103(6):801-5. doi: 10.1016/j.amjcard.2008.11.038. Epub 2009 Jan 24.

PMID:
19268735
11.

Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.

Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schömig A, Kastrati A, von Beckerath N.

J Am Coll Cardiol. 2009 Mar 10;53(10):849-56. doi: 10.1016/j.jacc.2008.11.030.

12.

High on treatment platelet reactivity and stent thrombosis.

Rajendran S, Parikh D, Shugman I, French JK, Juergens CP.

Heart Lung Circ. 2011 Aug;20(8):525-31. doi: 10.1016/j.hlc.2011.04.004. Epub 2011 May 17.

PMID:
21592858
13.

Drug-specific thienopyridine resistance in patient with recurrent coronary stent thrombosis.

Milicic D, Skoric B, Lovric D.

J Invasive Cardiol. 2009 Aug;21(8):E157-60.

PMID:
19652267
14.

The clopidogrel resistance can be attenuated with triple antiplatelet therapy in patients undergoing drug-eluting stents implantation.

Shim CY, Yoon SJ, Park S, Kim JS, Choi JR, Ko YG, Choi D, Ha JW, Jang Y, Chung N, Shim WH, Cho SY.

Int J Cardiol. 2009 May 29;134(3):351-5. doi: 10.1016/j.ijcard.2008.02.016. Epub 2008 Jun 24.

PMID:
18579227
15.
16.

High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patients.

Tavassoli N, Voisin S, Carrie D, Lapeyre-Mestre M, Galinier M, Montastruc JL, Pathak A.

Am J Cardiovasc Drugs. 2010;10(1):29-35. doi: 10.2165/11318260-000000000-00000.

PMID:
20104932
17.

Comparison of two antiplatelet regimens (aspirin alone versus aspirin + ticlopidine or clopidogrel) after intracoronary implantation of a carbofilm-coated stent.

Bartorelli AL, Tamburino C, Trabattoni D, Galassi A, Serdoz R, Sheiban I, Piovaccari G, Zimarino M, Benassi A, Di Mario C, Sangiorgio P, Chierchia S, Reimers B; Sorin Group.

Am J Cardiol. 2007 Apr 15;99(8):1062-6. Epub 2007 Mar 5.

PMID:
17437728
18.

Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.

Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, Yusuf S; Clopidogrel in Unstable angina to prevent Recurrent ischemic Events Trial.

Circulation. 2004 Sep 7;110(10):1202-8. Epub 2004 Aug 16.

20.

[Suspected clopidogrel resistance associated with recurrent coronary stent thrombosis--a case report].

Tomaszuk-Kazberuk A, Sobkowicz B, Usowicz-Szaryńska M, Prokop JB, Knapp M, Sawicki R, Musiał WJ.

Kardiol Pol. 2007 Jul;65(7):810-4; discussion 815-6. Polish.

Supplemental Content

Support Center